药明康德高位套现子公司,真有这么缺钱?

大众网
17 Jan

近日, 药明康德 通过两次大宗交易,出售了旗下子公司 药明合联 的股票,成功套现24.26亿港元。这一交易引发了市场的关注,一方面药明康德获得大笔资金,另一方面在业绩优良的情况下高位减持,有市场人士质疑是否对长期业绩的看空。具体来说,药明康德在2024年11月8日和2025年1月10日,通过大宗交易分别出售了药明合联8600万股股票,占药明合联总股本的7.17%。这笔交易的套现金额占经审计归属...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10